O-150 A phase II study of SGN-15 (cBR96-doxorubicin immunoconjugate) combined with docetaxel in patients with advanced stage or metastatic non-small cell lung cancer (NSCLC)
@article{Ross2003O150AP,
title={O-150 A phase II study of SGN-15 (cBR96-doxorubicin immunoconjugate) combined with docetaxel in patients with advanced stage or metastatic non-small cell lung cancer (NSCLC)},
author={H. Ross and C. Rudin and R. Figlin and L. Hart and M. Rarick and A. D. Jacobs and L. Grove and A. Sandler and C. Siegall and A. Sing},
journal={Lung Cancer},
year={2003},
volume={41}
}